Formulation, Optimization and Evaluation of Sustained Release Microspheres using Taguchi Design
Home >
2014,
Vol. 2 No. 1 > Formulation, Optimization and Evaluation of Sustained Release Microspheres using Taguchi Design
Authors
- Sukhbir SinghChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- Sandeep AroraChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- NeelamChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- Dharna AllawadiChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
Keywords
Taguchi, Response Variables, Independent Variables, Drug Entrapment Efficiency, Drug Loading, Higuchi Model
Abstract
The aim of present study is to prepare microspheres of eudragit RL 100 loaded with Nefopam Hydrochloride by single emulsion solvent evaporation technique. Taguchi L9 orthogonal array design has been used to optimize the composition and operating conditions for preparation of formulations. Nine batches (F1-F9) were prepared by taking three independent variables (X1- drug: polymer ratio, X2- stirring speed and X3- stirring time) at three levels (+1, 0, -1). Response variables studied for batches (F1-F9) were mean particle size (ĂÂŒm) (Y1), drug entrapment efficiency (% w/w) (Y2) and drug loading (% w/w) (Y3). Drug- polymer compatibility study was carried out by DSC and FTIR spectroscopy and indicates no physicochemical interaction. Microspheres were analyzed for morphological characteristics, mean particle size, drug entrapment efficiency, drug loading and in-vitro drug release. Percentage cumulative drug release for optimized batch F5 was found to be 85.421 ñ 0.054 and followed higuchi model for release of drug.
References
- Alfonsi, P. Adam, F. Assard, A. Guignard, B. Sessler, D. I. and Chauvin, M. (2004) âNefopam, a Non-sedative Benzoxazocine Analgesic, Selectively Reduces the Shivering Thresholdâ. Anesthesiology, 100, 1, 37â43.
- Arindam, H. and Biswanath, S. (2006) âPreparation and In-vitro evaluation of Polystyrene-Coated (PS-coated) microcapsule of drug-resin complex for achieving prolonged release of Diltiazem Hydrochlorideâ. AAPS PharmSciTech, 7, 2, 34-49. https://doi.org/10.1208/pt070246
- Aymard, G. Warot, D. and Demolis, P. (2003) âComparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteersâ. Pharmacoogy & Toxicology, 92, 279-86. https://doi.org/10.1034/j.1600-0773.2003.920605.x
- Barratt, G. M. (2000) âTherapeutic applications of colloidal drug carriersâ. Pharmaceutical Science and Technology Today, 3, 5, 163-171. https://doi.org/10.1016/S1461-5347(00)00255-8
- Costa, P. Manuel, J. and Lobo, S. (2001) âModeling and comparison of dissolution profilesâ. European Journal of Pharmaceutical Sciences, 13, 123â133. https://doi.org/10.1016/S0928-0987(01)00095-1
- Das, S. K. and Das, N. G. (1998) âPreparation and in-vitro dissolution profile of dual polymer (Eudragit RS 100 and RL 100) microparticles of diltiazem hydrochlorideâ. Journal of Microencapsulation, 15, 445â452. https://doi.org/10.3109/02652049809006871
- Del, P. Damodharan, N. Mallick, S. Mukherjee, B. (2009) âDevelopment and Evaluation of Nefopam Transdermal Matrix Patch System in Human Volunteersâ. Parenteral Drug Association Journal of Pharmaceutical Sciences and Technology, 63, 6, 537-546.
- Gholap, S. B. Banarjee, S. K. Gaikwad, D.D. Jadhav, S. L. and Thorat, R.M. (2010) âHollow Microsphere: A Reviewâ. International Journal of Pharmaceutical Sciences Review and Research, 1, 1, 74-79.
- Jose, S. Fangueiro, J. F. Smitha, J. Cinu, T. A. Chacko, A. J. Premaletha, K. and Souto, E. B. (2012) âCross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testingâ. Colloids and Surfaces B: Biointerfaces, 92, 175-179. https://doi.org/10.1016/j.colsurfb.2011.11.040
- Kumar, A. and Sharma, P. K. and Banik, A. (2011) âMicroencapsulation as a novel drug delivery systemâ. Internationale Pharmaceutia Scientia, 1, 1, 1-7
- Kumar, R. and Majeti, N. V. (2000) âNano and microparticles as controlled drug delivery devicesâ. Journal of Pharmacy and Pharmaceutical Sciences, 3, 2, 234-258.
- Lee, J. H. Park, T. G. and Choi, H. K. (2000) âEffect of formulation and processing variables on the characteristics of microspheres for water soluble drugs prepared by w/o/o double emulsion solvent diffusion methodâ. International Journal of Pharmaceutics 196, 75â83. https://doi.org/10.1016/S0378-5173(99)00440-8
- Lewis, G. A. Mathieu, D. and Phan-Tan-Luu, R. (2005) âPharmaceutical Experimental Designâ (2nd Ed). Marcel Dekker, Inc., New York.
- Myers, R. H. Montgomery, D. C. Anderson-Cook, M. C. (1995) âResponse Surface Methodology Process and Product Optimization Using Designed Experimentsâ (3rd Ed). Wiley, New York.
- Neelesh, K. V. and Daniel, W. P. (2004) âMicrospheres for controlled release drug deliveryâ Expert Opinion on Biological Therapy, 4, 1, 1-17.
- Phutane, P. Shidhaye, S. Lotikar, V. Ghule, A. Sutar, S. and Kadam, V. (2010) âIn-vitro evaluation of Novel Sustained Release Microspheres of Glipzide prepared by the Emulsion Solvent Diffusionevaporation methodâ. Journal of Young Pharmacists, 2, 1, 35. https://doi.org/10.4103/0975-1483.62210
- Prasanth, V. V. Akash, C. M. Sam, T. M. and Rinku, M. (2011) âMicrospheres – An Overviewâ. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2, 2, 332-338
- Saharan, V. Kukkar, V. Kataria, M. Gera, M. and Choudhury, P. (2009) âDissolution enhancement of drugs. Part I: Technologies and effect of carriersâ. International Journal of Health Research, 2, 2, 107-124. https://doi.org/10.4314/ijhr.v2i2.55401
- Srivastava, A. K. Ridhurkar, D. N. and Wadhwa, S. (2005) âFloating Microspheres of Cimetidine: formulation, characterization and in-vitro evaluation. Acta Pharmaceutica, 55, 277â285.
- Starek, M. Browska, M. D. and Tarsa, M. (2011) âAnalysis of Nefopam by TLC-densitometry. A Study of Degradation Mechanism in Solutions under Stress Conditionsâ. Acta Chimica Slovenica, 58, 262â269.
- Taguchi, G. (1987) âSystem of Experimental Design. Engineering Methods to Optimize Quality and Minimize Costsâ. Kraus International, White Plains, New York.
- Umer, H. Nigam, H. Tamboli, A. M. and Moorthi, M. S. M. (2011) âMicroencapsulation: process, techniques and applicationsâ. International Journal of Pharmacy Research and Biological Sciences, 2, 2, 474-481.
- Varshosaz, J. Tavakoli, N. Minayian, M. and Rahdari, N. (2009) âApplying the Taguchi Design for Optimized Formulation of Sustained Release Gliclazide Chitosan Beads: An In-Vitro/In-Vivo Study. AAPS PharmSciTech, 10, 1, 158-165. https://doi.org/10.1208/s12249-009-9191-8
How to Cite
Sukhbir Singh, Sandeep Arora, Neelam, Dharna Allawadi. Formulation, Optimization and Evaluation of Sustained Release Microspheres using Taguchi Design.
J. Pharm. Technol. Res. Manag.. 2014, 02, 1-12
